Search
for
Sort by
Research 181–210 of 1000+
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Cutaneous manifestations associated with substance use disorders
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Lipid-based nanoformulation optimization for achieving cutaneous targeting: Niosomes as the potential candidates to fulfill this aim
- Trans-Epidermal Elimination Due to Insulin Formulation: Report of a Rare Adverse Effect
- Dermatologic Adverse Events from Cancer Treatments
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Safety and Efficacy of Mesotherapy with Placenta Polypeptide Injection for Moderate-to-Severe Sensitive Skin: A Multicenter, Randomized, Controlled Trial
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Urticariform plaques: delayed hypersensitivity reaction type IV to enoxaparin
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Vaping Culture and Cutaneous Health: A Trend with Skin-Deep Consequences
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Hypersensitivity Reactions to Anticoagulant Drugs
- Drug-induced acne
- Reporting on Adverse Clinical Events
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Alopecia areata after mogamulizumab treatment
- Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology
- Acupuncture for treating alopecia areata: A systematic review and meta-analysis
- Aceclofenac-induced erythema annulare centrifugum
- The efficacy of topical prostaglandin analogs for hair loss: A systematic review and meta-analysis
- Microneedles: Selected Applications for Pediatrics
- Madarosis: A marker of many Maladies